Chugai Pharmaceutical Co Ltd
TSE:4519
Chugai Pharmaceutical Co Ltd
TSE:4519
Price:
6 882
JPY
3.49%
Market Closed
Market Cap:
11.6T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Chugai Pharmaceutical Co Ltd
6882
+232 (+3.49%)
| 52 Week Range |
4 684
7 855
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Chugai Pharmaceutical Co Ltd
Balance Sheet
Balance Sheet Decomposition
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
| Current Assets | 1.3T |
| Cash & Short-Term Investments | 764.6B |
| Receivables | 240.9B |
| Other Current Assets | 316.4B |
| Non-Current Assets | 575.9B |
| PP&E | 426.4B |
| Intangibles | 19.6B |
| Other Non-Current Assets | 129.9B |
| Current Liabilities | 239B |
| Accounts Payable | 88.7B |
| Other Current Liabilities | 150.3B |
| Non-Current Liabilities | 16.7B |
| Other Non-Current Liabilities | 16.7B |
Balance Sheet
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
Currency: JPY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
114 037
|
101 707
|
95 368
|
139 074
|
146 860
|
203 941
|
212 333
|
267 753
|
222 169
|
458 674
|
|
| Cash |
0
|
0
|
91 580
|
136 219
|
140 912
|
195 514
|
205 734
|
261 331
|
215 619
|
440 517
|
|
| Cash Equivalents |
114 037
|
101 707
|
3 788
|
2 855
|
5 948
|
8 427
|
6 599
|
6 422
|
6 550
|
18 157
|
|
| Short-Term Investments |
116 030
|
134 419
|
120 909
|
106 125
|
104 737
|
134 169
|
166 287
|
204 217
|
280 938
|
280 308
|
|
| Total Receivables |
159 887
|
158 717
|
167 483
|
175 001
|
179 559
|
181 641
|
253 354
|
356 009
|
514 283
|
320 348
|
|
| Accounts Receivables |
141 322
|
134 450
|
140 699
|
148 471
|
150 778
|
139 628
|
195 632
|
281 319
|
436 383
|
252 530
|
|
| Other Receivables |
18 565
|
24 267
|
26 784
|
26 530
|
28 781
|
42 013
|
57 722
|
74 690
|
77 900
|
67 818
|
|
| Inventory |
139 571
|
161 135
|
185 440
|
169 056
|
159 360
|
168 122
|
183 893
|
208 838
|
292 206
|
273 480
|
|
| Other Current Assets |
9 379
|
11 795
|
9 560
|
9 885
|
9 577
|
11 807
|
19 039
|
26 844
|
26 941
|
33 616
|
|
| Total Current Assets |
538 904
|
567 773
|
578 760
|
599 141
|
600 093
|
699 680
|
834 906
|
1 063 661
|
1 336 537
|
1 366 426
|
|
| PP&E Net |
140 245
|
153 545
|
157 081
|
171 569
|
222 388
|
265 308
|
297 490
|
352 107
|
386 651
|
420 701
|
|
| PP&E Gross |
140 245
|
153 545
|
157 081
|
171 569
|
222 388
|
265 308
|
297 490
|
352 107
|
386 651
|
420 701
|
|
| Accumulated Depreciation |
152 396
|
154 253
|
164 631
|
176 284
|
181 566
|
194 235
|
209 647
|
218 950
|
238 196
|
203 701
|
|
| Intangible Assets |
11 286
|
13 511
|
19 299
|
21 078
|
22 699
|
23 540
|
23 880
|
21 974
|
25 141
|
19 860
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
9 723
|
2 958
|
3 029
|
11 776
|
11 474
|
12 505
|
|
| Other Long-Term Assets |
49 103
|
52 572
|
51 145
|
60 685
|
64 645
|
67 429
|
76 193
|
89 176
|
109 955
|
113 055
|
|
| Total Assets |
739 538
N/A
|
787 401
+6%
|
806 285
+2%
|
852 473
+6%
|
919 548
+8%
|
1 058 915
+15%
|
1 235 498
+17%
|
1 538 694
+25%
|
1 869 758
+22%
|
1 932 547
+3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
35 387
|
41 174
|
42 529
|
38 434
|
35 934
|
47 726
|
58 284
|
97 203
|
144 054
|
54 233
|
|
| Accrued Liabilities |
37 741
|
37 905
|
37 178
|
41 823
|
48 075
|
54 831
|
57 334
|
65 074
|
65 674
|
94 648
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
29
|
131
|
135
|
129
|
133
|
7 263
|
6 649
|
6 550
|
6 434
|
6 975
|
|
| Other Current Liabilities |
41 193
|
53 848
|
43 818
|
42 516
|
51 076
|
69 448
|
113 803
|
158 595
|
207 568
|
132 361
|
|
| Total Current Liabilities |
114 350
|
133 058
|
123 660
|
122 902
|
135 218
|
179 268
|
236 070
|
327 422
|
423 730
|
288 217
|
|
| Long-Term Debt |
185
|
604
|
510
|
207
|
82
|
5 489
|
4 635
|
9 490
|
7 675
|
6 480
|
|
| Deferred Income Tax |
10 722
|
10 028
|
9 146
|
9 211
|
9 031
|
9 304
|
9 166
|
7 614
|
7 086
|
5 787
|
|
| Minority Interest |
1 657
|
1 414
|
989
|
973
|
664
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
16 525
|
16 440
|
26 472
|
27 256
|
18 688
|
10 869
|
5 624
|
6 151
|
6 880
|
6 483
|
|
| Total Liabilities |
143 439
N/A
|
161 544
+13%
|
160 777
0%
|
160 549
0%
|
163 683
+2%
|
204 930
+25%
|
255 495
+25%
|
350 677
+37%
|
445 371
+27%
|
306 967
-31%
|
|
| Equity | |||||||||||
| Common Stock |
72 967
|
72 967
|
72 967
|
72 970
|
73 000
|
73 016
|
73 202
|
73 202
|
73 202
|
73 202
|
|
| Retained Earnings |
451 220
|
488 954
|
507 399
|
550 974
|
618 091
|
722 076
|
849 093
|
1 054 050
|
1 293 352
|
1 488 738
|
|
| Additional Paid In Capital |
67 317
|
62 567
|
63 500
|
64 815
|
66 043
|
67 037
|
67 586
|
68 223
|
68 806
|
69 355
|
|
| Unrealized Security Profit/Loss |
4 755
|
6 599
|
4 864
|
6 068
|
4 933
|
530
|
400
|
91
|
205
|
162
|
|
| Other Equity |
160
|
5 230
|
3 222
|
2 903
|
6 202
|
8 674
|
10 278
|
7 549
|
10 768
|
5 877
|
|
| Total Equity |
596 099
N/A
|
625 857
+5%
|
645 508
+3%
|
691 924
+7%
|
755 865
+9%
|
853 985
+13%
|
980 003
+15%
|
1 188 017
+21%
|
1 424 387
+20%
|
1 625 580
+14%
|
|
| Total Liabilities & Equity |
739 538
N/A
|
787 401
+6%
|
806 285
+2%
|
852 473
+6%
|
919 548
+8%
|
1 058 915
+15%
|
1 235 498
+17%
|
1 538 694
+25%
|
1 869 758
+22%
|
1 932 547
+3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
545
|
1 638
|
1 639
|
1 640
|
1 642
|
1 643
|
1 644
|
1 644
|
1 645
|
1 645
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
